| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.022 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.006 | 1 |